MD Candidate, University of Toronto & Junior Fellow, Massey College.
I have contributed to a major COVID-19 project, which features several current, former, and upcoming Oxford students. The project is called SeroTracker – we are tracking and synthesizing findings from SARS-CoV-2 antibody studies worldwide. Data from studies all over the world is displayed on our website SeroTracker.com – which launched on 27th May.
We have partnered with Canada’s COVID-19 Immunity Task Force, the federal government’s key organisation for battling COVID-19. They will support the administration of 1 million tests for SARS-CoV-2 antibodies over the next two years in Canada. The SeroTracker project was initiated in early April to serve the Task Force’s need for global serological testing data.
The SeroTracker team includes twenty researchers, developers, and economists from the University of Oxford, Harvard University, University of Toronto, University of Calgary, University of Waterloo, and McGill University. My contribution has been to lead the collection and synthesis of the global data on SARS-CoV-2 antibody studies.
The SeroTracker project will likely attract global attention. This project has the potential to inform the development of SARS-CoV-2 serosurveillance programs worldwide and will be of interest to clinicians, public health officials, and policymakers.